The Regenerative Outcomes Foundation is a 501(c)3 tax-exempt charitable organization that serves both patients seeking healing through regenerative medicine and the providers seeking to provide it. 

 

The emergence of regenerative medicine as a new paradigm of healthcare brings a need for rapid, decisive response to change. This is reflected in the way in which research is conducted, medicine is practiced, drugs are developed, and patients are healed.

​

We are currently offering, or preparing to offer several missional programs to:

 

• Give direct grants to patients. Through a fund we hope to establish by late 2018, patients will be eligible to receive cash grants to help cover travel, lodging and meal costs they may incur when they participate in, or pursue the treatments resulting from FDA Regenerative Medicine Advanced Therapy (RMAT) clinical trials;

• Provide direct consultation to providers. The new RMAT pathway to FDA approval is now available to cell therapy providers and biotech companies interested in sponsoring a clinical trial and marketing their innovative treatment or device. The Foundation's "RMAT Spectrum Services" program is a paid service that utilizes a global network of top scientists and regulatory experts in the Regenerative Medicine field who have joined with us in leveraging this powerful opportunity for clinicians and manufacturers to move this important segment of the industry through the regulatory process. For more information on RMAT Spectrum Services, contact us using the information below.

• Train patient ambassadors. Leading first by example, and then by specialized training, the "Ambassador Bridge" Project combines the unique power of personal narrative with professional mediation skills training to develop patient "Ambassadors," equipped to aid those involved in the Regenerative Medicine industry to communicate and understand each others' shared goals for patients, then use it collaboratively to drive public policy.

• Train cell therapy providers. The Regenerative Outcomes Foundation is dedicated to helping cell therapy providers understand the unique needs of patients considering or undergoing cell therapy treatments. Through education in ethics, patient engagement, specialized counseling, and robust methods for delivering informed consent, providers will have access to up-to-date information and materials that enable them to optimize their practices with patients, and optimize shared decision-making.

• Research and optimize treatment outcomes. There is much that providers and patients alike have yet to understand regarding the complex emotional, behavioral, social, and spiritual factors that impact patient outcomes, functioning, and quality of life. The Foundation partners with private and public sector stakeholders to help discover answers through specialized projects and clinical trial co-studies.

• Raise public, provider, and policymaker awareness. Engagement, interventions, responses, support, and follow up all describe common patient needs, but their expression is becoming increasingly more unique among regenerative medicine patients in particular. Therefore, the benefits of shared decision-making, and the role of specialized counseling on treatment outcomes, as well as ways to help patients thrive throughout engagement in the treatment process, become a priority for our consistent efforts at education. 

• Promote just regulatory policies. Access, self-determination, the right to information, affordability, and fair distribution of research funding are all critical to creating a national response to technologies with such tremendous healing potential and capability for reducing pain and suffering brought on by debilitating and serious conditions. Consistent with it's social justice roots, The Regenerative Outcomes Foundation leverages it's respected position within the stem cell space to maintain a "seat at the table" with a voice for equity in policy that emphasizes delivery of healing opportunities for all.

• Advance a cell therapy registry. Through strategic collaboration with nationally-recognized clinical, patient advocacy, research, and policy stakeholders, our advancement of a central cell therapy registry reflects our commitment to prioritize safety and efficacy first, and to inspire and motivate the public to support the ethical advancement of regenerative medicine.